NCT05847036

Brief Summary

Urinary tract infections (UTIs) are one of the most common bacterial infections managed in general practice: they are the 2nd site of community-acquired bacterial infection after respiratory infections (4-6 million consultations per year in France). UTIs represent 15% of total antibiotic prescriptions in France. Antibiotics recommended for UTIs, except for cystitis, are considered as "critical" (highly generating bacterial resistances). UTIs are a potential source of antibiotic resistance: often inappropriate antibiotic prescriptions, evolution of the resistance profiles of the bacteria involved, emergence of multi-resistant strains. The first hypothesis is that there are other profiles of clinical UTI situations in general practice than typical cystitis or pyelonephritis, including intermediate forms. The second hypothesis is that these intermediate forms of UTI are subject to longer durations of antibiotherapy, and that probable explanatory factors need to be identified.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

1.1 years

First QC Date

April 7, 2023

Last Update Submit

July 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome will be the number of homogeneous profiles of patients with UTI in general practice and their characteristics using clinico-bacteriological indicators.

    The primary outcome will be the rate and the clinical-bacteriological characteristics of the identified profiles of patients with UTI in general practice

    At Day 14 after the end of the Antiobiotic treatment

Secondary Outcomes (4)

  • For general practioners' practices:

    At Day 0, at Day 14 after the end of the treatment and between Day 0 and Day14 after the end of the treatment

  • For short-term evolutionary trajectories:

    At Day 0, at Day 14 after the end of the treatment and between Day 0 and Day 14 after the end of the treatment

  • For short-term evolutionary trajectories:

    At Day 14 after the end of the treatment

  • For the factors associated with the prescription of antibiotics:

    At Day 14 after the end of the treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients consulting in general practice for suspected urinary tract infection

You may qualify if:

  • Patient ≥18 years old
  • Patient presenting one or more of the following clinical signs suggestive of urinary tract infection in general practice consultation:
  • fever (temperature \> 38°C)
  • chills, sweats
  • burning urination
  • urinary urgency
  • pollakiuria
  • dysuria
  • lumbar and/or pelvic pain
  • abnormal urine appearance: cloudy, malodorous, macroscopic haematuria
  • absence of leucorrhoea
  • specifically in people \> 70 years old:
  • recent onset urinary incontinence
  • sudden confusion
  • bladder globe
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cabinet de groupe

Saint-Maur-des-Fossés, Saint Maur, 94100, France

RECRUITING

Related Publications (7)

  • Caron F, Galperine T, Flateau C, Azria R, Bonacorsi S, Bruyere F, Cariou G, Clouqueur E, Cohen R, Doco-Lecompte T, Elefant E, Faure K, Gauzit R, Gavazzi G, Lemaitre L, Raymond J, Senneville E, Sotto A, Subtil D, Trivalle C, Merens A, Etienne M. Practice guidelines for the management of adult community-acquired urinary tract infections. Med Mal Infect. 2018 Aug;48(5):327-358. doi: 10.1016/j.medmal.2018.03.005. Epub 2018 May 16. No abstract available.

    PMID: 29759852BACKGROUND
  • Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014 Oct 22-29;312(16):1677-84. doi: 10.1001/jama.2014.12842.

    PMID: 25335150BACKGROUND
  • Soudais B, Lacroix-Hugues V, Meunier F, Gillibert A, Darmon D, Schuers M. Diagnosis and management of male urinary tract infections: a need for new guidelines. Study from a French general practice electronic database. Fam Pract. 2021 Jul 28;38(4):432-440. doi: 10.1093/fampra/cmaa136.

    PMID: 33340317BACKGROUND
  • Kinouani S, de Lary de Latour H, Joseph JP, Letrilliart L. Diagnostic strategies for urinary tract infections in French general practice. Med Mal Infect. 2017 Oct;47(6):401-408. doi: 10.1016/j.medmal.2017.05.003. Epub 2017 Jun 9.

    PMID: 28606664BACKGROUND
  • Vincent YM, Frachon A, Buffeteau C, Conort G. Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care. BMC Fam Pract. 2021 Jan 26;22(1):26. doi: 10.1186/s12875-021-01374-3.

    PMID: 33499824BACKGROUND
  • Piraux A, Faure S, Naber KG, Alidjanov JF, Ramond-Roquin A. Changes in the management of urinary tract infections in women: impact of the new recommendations on antibiotic prescribing behavior in France, between 2014 and 2019. BMC Health Serv Res. 2021 Jun 28;21(1):612. doi: 10.1186/s12913-021-06653-4.

    PMID: 34182991BACKGROUND
  • Lugtenberg M, Burgers JS, Zegers-van Schaick JM, Westert GP. Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions. BMC Fam Pract. 2010 Jun 28;11:51. doi: 10.1186/1471-2296-11-51.

    PMID: 20584276BACKGROUND

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Véronique ORCEL, Dr

    Département Universitaire d'Enseignement et de Recherche de Médecine Générale de Créteil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2023

First Posted

May 6, 2023

Study Start

December 15, 2023

Primary Completion

January 31, 2025

Study Completion

January 31, 2025

Last Updated

July 3, 2024

Record last verified: 2024-07

Locations